SEC Form D · filed April 8, 2022
Transition Bio, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Al K. Sandrock · CAMBRIDGE, MADirectorGregory L. Miller · CAMBRIDGE, MAExec · DirectorTuomas L. Knowles · CAMBRIDGE, MAExecSamuel K. Cohen · CAMBRIDGE, MADirectorGeorge K. Martin · CAMBRIDGE, MADirectorMartin L. Kulander · CAMBRIDGE, MAExecStephanie L. Torruella · CAMBRIDGE, MAExecAnthony Salewski · San Francisco, CAExec · DirectorLori Hardwick · San Francisco, CADirectorMichael Durbin · San Francisco, CAExecSiddharth Ramakrishnan · San Francisco, CADirectorGary Michel · San Francisco, CADirectorBen Brigeman · San Francisco, CAExecShaan K. Gandhi · CAMBRIDGE, MADirectorShawn O'Neil · Aliso Viejo, CADirectorTibor Juhasz · Aliso Viejo, CAExecWilliam Link · Aliso Viejo, CAExec · DirectorTom Frinzi · Aliso Viejo, CADirectorRebecca A. Bell · Macon, GAExecManeklal G. Patel · Macon, GADirectorStephanie L. Torruella · CAMBRIDGE, MAExecShaan K. Gandhi · CAMBRIDGE, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗